drugset / Trial / NCT01216865

Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot

NCT01216865

Phase 1/2 Unknown 50 enrolled Qingdao University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for diabetic foot is safe and effective in the management of diabetic foot ischemia, the therapeutic effect of stem cells is caused by improving blood circulation in ischemic limb which would in turn promote ulcer healing, prevent amputation of limb and relieve the Sevier pain of ischemia.

Timeline

Start
2011-01
Primary completion
2012-12
Completion
2013-07

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 5e+07 cells Intramuscular

Indications